Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0162871 (
abdominal aortic aneurysm
)
8,664
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Machado-Joseph disease (MJD)/Spinocerebellar ataxia type 3 (SCA3) is neurodegenerative disease which is caused by polyglutamine expansion in a responsible gene product,
MJD1
/Ataxin3.
MJD1
has now been shown to undergo ubiquitylation and degradation by proteasome-dependent pathway.
MJD1
with expanded polyglutamine tract was more resistant to degradation than normal
MJD1
. We established an in vitro system of ubiquitylation of
MJD1
, thereby biochemically purified activity to mediate polyubiquitylation of
MJD1
from rabbit reticulocyte lysate. An
AAA
-family ATPase VCP was isolated from the active fraction, and found to binds to
MJD1
. Furthermore, UFD2a, a mammalian ubiquitin-chain assembly factor (E4), associated with VCP and induced polyubiquitylation of
MJD1
. UFD2a markedly promoted ubiquitylation and degradation of
MJD1
with expanded polyglutamine tract, resulting in the clearance of MJD1 protein. In contrast, dominant-negative mutant UFD2a reduced the degradation rate of
MJD1
, leading to the formation of intracellular aggregation. In Drosophila model, overexpression of UFD2a significantly suppressed the neurodegeneration induced by expression of
MJD1
with expanded polyglutamine tract. These findings suggest that E4 is a rate-limiting factor of degradation of pathologic polyglutamine-containing proteins, and may give a potential tool for gene therapy to control the clinical conditions of MJD.
...
PMID:[Mechanisms to control degradation of polyglutamine-containing protein]. 1515
Various inherited neurodegenerative diseases result from an increase in the number of glutamine codon repeats within the open reading frame of the responsible gene. Insoluble aggregates of polyglutamine-containing proteins in neurons, which are usually conjugated with ubiquitin, are a hallmark of the polyglutamine diseases. However, the molecular mechanism underlying the ubiquitylation and aggregate formation of polyglutamine-containing proteins has been largely unclear. Here we report the identification of critical factors involved in the ubiquitylation process as well as turnover of
MJD1
/Ataxin-3 protein, in which the abnormal expansion of a polyglutamine tract is responsible for spinocerebellar ataxia type 3 (
SCA3
, also known as Machado-Joseph disease). E4 B/UFD2a (a ubiquitin chain assembly factor) and VCP (a
AAA
-family ATPase) were co-purified with the activity polyubiquitylating Ataxin-3. E4B mediated polyubiquitylation of
MJD1
/Ataxin-3, and VCP interacted with both E 4B and
MJD1
Ataxin-3. In a Drosophila model of
SCA3
, expression of E4B suppressed the neurodegeneration induced by an Ataxin-3 mutant. These observations suggest that E4 is a rate-limiting factor in the degradation of proteins with expanded polyglutamine tracts.
...
PMID:[Neurodegenerative diseases regulated by ubiquitin-proteasome system]. 1743 11